Milestone Pharmaceuticals Inc. (MIST)
↓ Download CSVKey ratios (FY2025)
-151.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$62.14M | -$42.10M | -$61.10M | -$59.64M | -$43.07M | -$50.71M | -$57.88M | -$23.82M | — |
| Net Income | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M | -$49.97M | -$55.23M | -$23.18M | — |
| EPS (Diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | — | — | — |
| Total Assets | $113.56M | $75.50M | $75.23M | $74.48M | $119.85M | $149.97M | $123.43M | $88.08M | — |
| Total Liabilities | $71.79M | $62.35M | $58.45M | $8.13M | $7.25M | $6.86M | $8.51M | $4.53M | — |
| Shareholders' Equity | $41.77M | $13.15M | $16.77M | $66.35M | $112.60M | $143.12M | $114.92M | $83.55M | $25.98M |
| Cash & Equivalents | $73.05M | $25.31M | $13.76M | $7.64M | $114.14M | $72.31M | $119.82M | $85.95M | — |
| Operating Cash Flow | -$49.04M | -$28.85M | -$46.42M | -$52.47M | -$33.22M | -$50.73M | -$51.15M | -$21.05M | — |
| Capital Expenditures | $302.0K | $33.0K | $112.0K | $272.0K | — | — | $413.0K | $5.0K | — |
| Shares Outstanding | 106.24M | 53.35M | 33.48M | 34.29M | 29.90M | 29.83M | 24.51M | 596.8K | — |